The Dr. Tyna Show The Functional Pharmacist: Ivermectin with Dr. John Kim
19 snips
Jul 21, 2021 Dr. John Kim is a New Jersey-based pharmacist and functional medicine practitioner specializing in integrative medicine. He discusses the controversial use of ivermectin as a treatment for COVID-19 and the political hurdles surrounding it. The conversation dives into how viruses behave, the impact of lockdowns, and the reliability of PCR testing. Dr. Kim also explains ivermectin's broader applications beyond parasites, and the importance of sharing accurate health information, especially for underprivileged populations.
AI Snips
Chapters
Transcript
Episode notes
Reduces Key Cytokine Drivers Of Severe Disease
- Ivermectin lowers interleukin-6 and dampens the cytokine cascade that drives severe COVID complications.
- The drug may reduce clotting, pulmonary embolism risk, and downstream lung fibrosis by modulating inflammation.
Real‑World Use In Peru And India
- Dr. Tyna reports hospitals in Peru and India distributed ivermectin widely and saw mild case burdens when broadly used.
- She and Dr. John link national ivermectin use to lower case severity in some regions.
Politics Shaped Access To Repurposed Drugs
- Repurposed drugs like hydroxychloroquine and ivermectin were politicized and restricted, limiting clinician access early in the pandemic.
- Regulatory actions and media narratives influenced prescribing and availability rather than pure clinical data.